RIGI and atherosclerosis: Overexpression of IFN-I through the activation of TLR7/9 signal decreases the number and function of EPCs and increases atherosclerotic lesions in SLE patients (46), suggesting that targeted therapy of cGAS and RIG-I signal pathway may have a potential therapeutic effect on SLE atherosclerosis.